BANK OF AMERICA SPENDS $250 MILLION A YEAR ON GLP-1 DRUGS FOR ITS EMPLOYEES, CEO SAYS - CNBC

CEO disclosure of $250 million annual GLP-1 employee spend signals material corporate healthcare cost exposure.